23 Followers on Owler

Neurogene

is a pharmaceutical company that develops and commercializes genetic medicines for the treatment of neurological diseases... Read more
OverviewCompetitorsFundingNews & Insights

Neurogene

is a pharmaceutical company that develops and commercializes genetic medicines for the treatment of neurological diseases... Read more
Neurogene CEO: Rachel McMinn

CEO

Rachel McMinn

CEO Approval Rating

88/100

2018

PublicMerged with Neoleukin Therapeutics, Inc.NASDAQNGNE

Pharmaceuticals & Biotechnology
Pharmaceuticals
28342836 NAICS listing

Annual Revenue
$ < 1M
Employees
90
Funding
$383.5M

News

Funding
Nov 04, 2024
Business Wire
Neurogene received $200M in PIPE Funding

Neurogene Competitors

1NeuroNascent
2Neurona Therapeutics
3Denali
4BrainStorm
5Aqua Serv
6Maryland Select Homes
7ProMIS Neurosciences
Unlock 4 + competitors

Trending Companies